Publications
302 results found
Cufari ME, Proli C, Phull M, et al., 2015, Increasing Incidence of Non-Smoking Lung Cancer: Presentation of Patients with Early Disease to a Tertiary Institution in the UK, JOURNAL OF THORACIC ONCOLOGY, Vol: 10, Pages: S220-S220, ISSN: 1556-0864
Viola P, Devaraj A, Lim E, et al., 2015, Pathology-Imaging Agreement in Distinguishing Separate Primary Tumours and Intrapulmonary Metastasis in Staging of Multiple Lung Cancers, Publisher: ELSEVIER SCIENCE INC, Pages: S261-S262, ISSN: 1556-0864
McElnay PJ, Choong A, Jordan E, et al., 2015, Outcome of surgery versus radiotherapy after induction treatment in patients with N2 disease: systematic review and meta-analysis of randomised trials, THORAX, Vol: 70, Pages: 764-768, ISSN: 0040-6376
- Author Web Link
- Cite
- Citations: 55
Freidin MB, Freydina DV, Fernandez AM, et al., 2015, Application of RNA in situ hybridisation for identification of circulating tumour cells, JOURNAL OF CLINICAL PATHOLOGY, Vol: 68, Pages: 669-U89, ISSN: 0021-9746
- Author Web Link
- Cite
- Citations: 2
Caplin ME, Baudin E, Ferolla P, et al., 2015, Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids, ANNALS OF ONCOLOGY, Vol: 26, Pages: 1604-1620, ISSN: 0923-7534
- Author Web Link
- Cite
- Citations: 398
Eberhardt WEE, De Ruysscher D, Weder W, et al., 2015, 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer, ANNALS OF ONCOLOGY, Vol: 26, Pages: 1573-1588, ISSN: 0923-7534
- Author Web Link
- Cite
- Citations: 262
Green AC, Marx A, Stroebel P, et al., 2015, Type A and AB thymomas: histological features associated with increased stage, HISTOPATHOLOGY, Vol: 66, Pages: 884-891, ISSN: 0309-0167
- Author Web Link
- Cite
- Citations: 18
Al-Sahaf M, Lim E, 2015, The association between surgical volume, survival and quality of care, JOURNAL OF THORACIC DISEASE, Vol: 7, Pages: S152-S155, ISSN: 2072-1439
- Author Web Link
- Cite
- Citations: 36
Pattenden HA, Leung M, Beddow E, et al., 2015, Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours, THORAX, Vol: 70, Pages: 379-381, ISSN: 0040-6376
- Author Web Link
- Cite
- Citations: 20
Lim E, Nicholson AG, Padley S, et al., 2015, Never smoker with ground glass opacities on CT, LANCET RESPIRATORY MEDICINE, Vol: 3, Pages: 328-328, ISSN: 2213-2600
- Author Web Link
- Cite
- Citations: 1
Sharkey A, Ariyaratnam P, Anikin V, et al., 2015, Thoracoscore and European Society objective score fail to predict mortality in the UK, World Journal of Oncology, Vol: 6, Pages: 270-275, ISSN: 1920-4531
Background: Thoracoscore and the European Society Objective Score (ESOS.01) are two scoring systems used in thoracic surgery to estimate operative mortality risk. We aimed to evaluate if these are valid tools for use in the UK population. Methods: A multi-center, prospective study was carried out on patients undergoing lung resection at six UK centers. Data were submitted electronically using our online data collection tool. Data were analyzed to determine the factors affecting mortality. A receiver operating characteristic analysis determined the ability of the thoracoscore and ESOS.01 to predict in-hospital mortality. Results: Data were complete for 2,245 patients. The observed in-hospital mortality was 31 patients (1.38%). Mean thoracoscore was 2.66 (SD ± 3.21). Gender (P = 0.004, hazard ratio 4.786) and co-morbidity score (P = 0.005, hazard ratio 3.289) were identified as risk factors for mortality. A sub-analysis was performed using data from 1,912 patients with complete data for ESOS.01. In this group, mean thoracoscore was 2.55 (SD ± 2.94), mean ESOS.01 was 2.11(SD ± 1.41), and these were statistically significantly different (P < 0.0001). The observed in-hospital mortality was 28 patients (1.46%). The c-index for thoracoscore was 0.705, and for ESOS.01 was 0.739. Conclusions: Both thoracoscore and ESOS.01 overestimated mortality in the UK population. There is a continued need to develop an appropriate risk prediction system for the UK.
Opitz I, Bueno R, Lim E, et al., 2015, Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know (vol 46, pg 602, 2014), EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, Vol: 47, Pages: 200-200, ISSN: 1010-7940
Freydina DV, Chudasama D, Freidin MB, et al., 2015, Diagnostic Utility of Unbiased Circulating Tumour Cell Capture through Negative Depletion of Peripheral Blood Cells, ONCOLOGY, Vol: 89, Pages: 360-364, ISSN: 0030-2414
- Author Web Link
- Cite
- Citations: 3
Lim E, 2014, Basic statistics (the fundamental concepts), JOURNAL OF THORACIC DISEASE, Vol: 6, Pages: 1878-1881, ISSN: 2072-1439
- Author Web Link
- Cite
- Citations: 2
Pan D, Cufari ME, Lim E, 2014, Beware of arteria lusoria during lymph node dissection of the right paratracheal fossa for lung cancer surgery, JOURNAL OF THORACIC DISEASE, Vol: 6, Pages: E264-E266, ISSN: 2072-1439
- Author Web Link
- Cite
- Citations: 1
Opitz I, Bueno R, Lim E, et al., 2014, Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, Vol: 46, Pages: 602-606, ISSN: 1010-7940
- Author Web Link
- Cite
- Citations: 3
Rintoul RC, Ritchie AJ, Edwards JG, et al., 2014, Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial, LANCET, Vol: 384, Pages: 1118-1127, ISSN: 0140-6736
- Author Web Link
- Cite
- Citations: 137
Freydin M, Freydina DV, Chudasama D, et al., 2014, 200PA BLOOD BASED EGFR MUTATION ANALYSIS IN CIRCULATING PLASMA DNA FOR PREDICTION OF PRIMARY TUMOUR MUTATIONS IN LUNG CANCER., Ann Oncol, Vol: 25, Pages: iv68-iv69
Nicholson AG, Detterbeck FC, Marino M, et al., 2014, The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the T component for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors, JOURNAL OF THORACIC ONCOLOGY, Vol: 9, Pages: S73-S80, ISSN: 1556-0864
- Author Web Link
- Cite
- Citations: 108
Kerr KM, Bubendorf L, Edelman MJ, et al., 2014, Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer, ANNALS OF ONCOLOGY, Vol: 25, Pages: 1681-1690, ISSN: 0923-7534
- Author Web Link
- Cite
- Citations: 203
Ruffini E, Detterbeck F, Van Raemdonck D, et al., 2014, Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, Vol: 46, Pages: 361-368, ISSN: 1010-7940
- Author Web Link
- Cite
- Citations: 121
Detterbeck FC, Stratton K, Giroux D, et al., 2014, The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors, JOURNAL OF THORACIC ONCOLOGY, Vol: 9, Pages: S65-S72, ISSN: 1556-0864
- Author Web Link
- Cite
- Citations: 263
Kondo K, Van Schil P, Detterbeck FC, et al., 2014, The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the N and M Components for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors, JOURNAL OF THORACIC ONCOLOGY, Vol: 9, Pages: S81-S87, ISSN: 1556-0864
- Author Web Link
- Cite
- Citations: 81
Freidin MB, Tay A, Freydina DV, et al., 2014, An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer, LUNG CANCER, Vol: 85, Pages: 182-185, ISSN: 0169-5002
- Author Web Link
- Cite
- Citations: 40
Vansteenkiste J, Crino L, Dooms C, et al., 2014, 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up, ANNALS OF ONCOLOGY, Vol: 25, Pages: 1462-1474, ISSN: 0923-7534
- Author Web Link
- Cite
- Citations: 357
Filosso PL, 2014, Knowledge of Pulmonary Neuroendocrine Tumors: Where Are We Now? Preface, THORACIC SURGERY CLINICS, Vol: 24, Pages: IX-XII, ISSN: 1547-4127
- Author Web Link
- Cite
- Citations: 3
Besse B, Adjei A, Baas P, et al., 2014, 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease, ANNALS OF ONCOLOGY, Vol: 25, Pages: 1475-1484, ISSN: 0923-7534
- Author Web Link
- Cite
- Citations: 188
Lim E, Tay A, Von Der Thusen J, et al., 2014, Clinical results of microfluidic antibody-independent peripheral blood circulating tumor cell capture for the diagnosis of lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, Vol: 147, Pages: 1936-1938, ISSN: 0022-5223
- Author Web Link
- Cite
- Citations: 12
Lim EKS, Freidin MB, Freydina DV, et al., 2014, A comparative study of blood-based <i>KRAS</i> mutation analysis in circulating tumor cells versus circulating plasma DNA to predict primary tumor mutations in lung cancer., 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Publisher: LIPPINCOTT WILLIAMS & WILKINS, ISSN: 0732-183X
Brunelli A, Falcoz PE, D'Amico T, et al., 2014, European guidelines on structure and qualification of general thoracic surgery, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, Vol: 45, Pages: 779-786, ISSN: 1010-7940
- Author Web Link
- Cite
- Citations: 36
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.